- Report
- April 2023
- 147 Pages
Global
From €4594EUR$4,949USD£3,835GBP
- Report
- April 2023
- 147 Pages
Global
From €4594EUR$4,949USD£3,835GBP
- Report
- May 2024
- 139 Pages
Global
From €3712EUR$3,999USD£3,099GBP
- Report
- May 2024
- 134 Pages
Global
From €3712EUR$3,999USD£3,099GBP
- Report
- July 2024
- 200 Pages
Global
From €4594EUR$4,949USD£3,835GBP
- Report
- September 2025
- 205 Pages
Global
From €4636EUR$4,995USD£3,870GBP
- Report
- June 2024
- 200 Pages
Global
From €4636EUR$4,995USD£3,870GBP
- Report
- August 2025
- 118 Pages
Global
From €16703EUR$17,995USD£13,944GBP
- Report
- June 2025
- 101 Pages
Global
From €16703EUR$17,995USD£13,944GBP
- Report
- February 2023
- 48 Pages
Global
From €3708EUR$3,995USD£3,096GBP
- Report
- September 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,758GBP
- Report
- September 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,758GBP
- Report
- August 2025
- 150 Pages
Global
From €4502EUR$4,850USD£3,758GBP
- Report
- November 2024
- 150 Pages
Global
From €4502EUR$4,850USD£3,758GBP
- Report
- October 2025
- 160 Pages
Global
From €2933EUR$3,160USD£2,449GBP
€3666EUR$3,950USD£3,061GBP
- Report
- October 2025
- 160 Pages
Global
From €2933EUR$3,160USD£2,449GBP
€3666EUR$3,950USD£3,061GBP
- Report
- October 2025
- 160 Pages
Global
From €2933EUR$3,160USD£2,449GBP
€3666EUR$3,950USD£3,061GBP
- Report
- October 2025
- 160 Pages
Global
From €2933EUR$3,160USD£2,449GBP
€3666EUR$3,950USD£3,061GBP
- Report
- August 2025
- 150 Pages
Global
From €2933EUR$3,160USD£2,449GBP
€3666EUR$3,950USD£3,061GBP
- Report
- October 2021
- 288 Pages
Global
From €3341EUR$3,600USD£2,790GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more